We Analyze and Interpret Human Genome Data to provide a comprehensive view of the Mutations. The variants are ranked to best match the disease or phenotype in question. Our reports provide clear information on actionable and clinically relevant gene mutation and variation. Variants are also analysed to report drug response and pharmacogenomic data.
We curate information from various databases to unearth the role of mutations in disease and drug response. All information is validated thoroughly and cross checked for clinical relevance.
Submit your Raw File and a get a detailed Analysis Report on Genetic Conditions & Drug Response. All our reports are generated in a clinically relevant time frame. Our reports also contain all necessary files to view on various Genome Visualization Browsers.
Advancement in Sequencing Technology are helping Clinicians make the right Diagnosis in patients. From ambiguous tumors to rare genetic conditions, genomic information is adding value in Diagnosis. Leucine Rich Bio augments diagnosis from genomics data by accurately compiling a list of actionable mutations. The mutations are ranked to best explain the phenotype in question.
Clinical Sequencing of Human Genome is helping Doctors unearth the Genetic Condition of their patients. There are many gene mutations that could explain the condition presented. Leucine Rich Bio provides a robust system of evaluation to predict precisely the causal genetic variant.
Pharmacogenomics is playing a big role in selecting the right therapeutic. The question of which drug and at what dosage is being answered through sequencing technologies. Leucine Rich Bio provides comprehensive reports detailing the response of drugs based on an individual’s genome. Our reports will guide clinicians to choose the right Theranostic approach.
Next Generation Sequencing technologies is revolutionizing Personalized Medicine especially in Oncology. From ambiguous tumors to prevalent cancer, advances in sequencing technologies are predicting the right therapy for patients. Leucine Rich Bio’s robust platforms elucidates the right therapy for Cancer Patients. Our physician tailored reports offers clinically significant analysis of actionable mutations for better Theranostic Value.
There are over 8000 Rare or Orphan diseases and about 85% of them are genetic in Nature. Advances in sequencing technologies have helped clinicians identify the root cause of these diseases. Leucine Rich Bio’s robust platforms are powerful tools for diagnosis of Genetic and Mendilian Disorders. We provide comprehensive reports on the causative genetic variants.